No Picture
Trading Ideas

Heron Therapeutics: HTX-011 Will Eventually Be Approved, Says Analyst

It was a difficult start to the week for Heron Therapeutics (HRTX). Monday saw shares plunge after the small-cap biotech received another CRL (complete response letter) for its experimental post-operative pain medication, HTX-011.Following the verdict, Stifel analyst Derek Archila acknowledges that the current sentiment surrounding HRTX is negative, but he remains optimistic about the candidate.“While we think investors are losing confidence/patience with HRTX on getting HTX-011 over the goal line (2 CRLs and a PDUFA extension), the issues raised by the FDA in the CRL appear to be of a minor nature, and management’s commentary on the conference call make …read more […]

No Picture
Trading Ideas

Should Value Investors Buy Qualcomm (QCOM) Stock?

If you are looking for the best ideas for your portfolio you may want to consider some of Amana Mutual Funds top stock picks. Amana Mutual Funds, an investment management firm, is bullish on Qualcomm Inc (NASDAQ:QCOM) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed […] …read more […]

No Picture
Trading Ideas

If You Own Intuit (INTU) Stock, Should You Sell It Now?

If you are looking for the best ideas for your portfolio you may want to consider some of Amana Mutual Funds top stock picks. Amana Mutual Funds, an investment management firm, is bullish on Intuit Inc (NASDAQ:INTU) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed […] …read more […]

No Picture
Trading Ideas

Has Inovio Stock Surged Enough for Now? This Analyst Says Yes

The frantic global search for a vaccine or therapy for the coronavirus has sent the valuations of previously small cap biotechs to unimagined heights over a short period of time. There can’t be many better examples for the phenomenon than Inovio Pharmaceuticals (INO). Investors have cheered the progress of its COVID-19 DNA vaccine candidate INO-4800 by sending shares on a mightily impressive run – the stock is up by 505% since the turn of the year (even after today’s 25% sell off).The massive gains, the richly valued $3.2 billion market cap and a track record that – while promising – …read more […]

No Picture
Trading Ideas

EU in talks with Gilead to get remdesivir doses for EU countries

The European Commission said on Wednesday it was in negotiations with Gilead Sciences Inc to obtain doses of COVID-19 antiviral remdesivir for the 27 European Union countries. The Commission said it took note of the announcement that the United States had secured nearly all of Gilead’s projected production capacity for the next three months. …read more […]

No Picture
Trading Ideas

Here’s Why Apple (AAPL) Stock Could be a Solid ‘Buy’ in Today’s Market

If you are looking for the best ideas for your portfolio you may want to consider some of Amana Mutual Funds top stock picks. Amana Mutual Funds, an investment management firm, is bullish on Apple Inc. (NASDAQ:AAPL) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed […] …read more […]